▶ 調査レポート

薬物乱用テストの世界市場 2020年:企業別、地域別、種類・用途別

• 英文タイトル:Global Drug Abuse Testing Market 2020 by Company, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。薬物乱用テストの世界市場 2020年:企業別、地域別、種類・用途別 / Global Drug Abuse Testing Market 2020 by Company, Regions, Type and Application, Forecast to 2025 / D005-00312資料のイメージです。• レポートコード:D005-00312
• 出版社/出版日:GlobalInfoResearch / 2020年5月29日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、104ページ
• 納品方法:Eメール
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、薬物乱用テストの世界市場を広く調査・分析し、今後の市場展望をまとめております。薬物乱用テストの種類別市場規模(就職テスト、ランダムテスト、合理的テスト、事故後テスト、追跡テスト)、用途別市場規模(学校&教育機関、病院&ヘルスケア部門、政府&民間部門)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):Biomedical Diagnostics、Fujirebio、Bio-Rad、BioMerieux、Eiken、Abbott、DiaSorin、Dako、Beckman Coulter
・地域別グローバル市場分析 2015年-2020年
・薬物乱用テストの北米市場(アメリカ、カナダ、メキシコ)
・薬物乱用テストのヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・薬物乱用テストのアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・薬物乱用テストの南米市場(ブラジル、アルゼンチン)
・薬物乱用テストの中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:就職テスト、ランダムテスト、合理的テスト、事故後テスト、追跡テスト
・用途別分析:学校&教育機関、病院&ヘルスケア部門、政府&民間部門
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論

Market Overview
The global Drug Abuse Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.4% in the forecast period of 2020 to 2025 and will expected to reach USD 8089.3 million by 2025, from USD 6322 million in 2019.

The Drug Abuse Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Drug Abuse Testing market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Drug Abuse Testing market has been segmented into:
Employment testing
Random testing
Reasonable testing
Post accident testing
Follow-up testing

By Application, Drug Abuse Testing has been segmented into:
Schools and educational institutes
Hospitals and healthcare units
Government and private departments

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Drug Abuse Testing market presented in the report. This section sheds light on the sales growth of different regional and country-level Drug Abuse Testing markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Drug Abuse Testing market.

The report offers in-depth assessment of the growth and other aspects of the Drug Abuse Testing market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Drug Abuse Testing Market Share Analysis
Drug Abuse Testing competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Drug Abuse Testing sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Drug Abuse Testing sales, revenue and market share for each player covered in this report.

The major players covered in Drug Abuse Testing are:
Biomedical Diagnostics
Fujirebio
Bio-Rad
BioMerieux
Eiken
Abbott
DiaSorin
Dako
Beckman Coulter

レポート目次

Table of Contents

1 Drug Abuse Testing Market Overview
1.1 Product Overview and Scope of Drug Abuse Testing
1.2 Classification of Drug Abuse Testing by Type
1.2.1 Global Drug Abuse Testing Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Drug Abuse Testing Revenue Market Share by Type in 2019
1.2.3 Employment testing
1.2.4 Random testing
1.2.5 Reasonable testing
1.2.6 Post accident testing
1.2.7 Follow-up testing
1.3 Global Drug Abuse Testing Market by Application
1.3.1 Overview: Global Drug Abuse Testing Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Schools and educational institutes
1.3.3 Hospitals and healthcare units
1.3.4 Government and private departments
1.4 Global Drug Abuse Testing Market by Regions
1.4.1 Global Drug Abuse Testing Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Drug Abuse Testing (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Drug Abuse Testing Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Drug Abuse Testing Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Drug Abuse Testing Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Drug Abuse Testing Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Drug Abuse Testing Status and Prospect (2015-2025)
2 Company Profiles
2.1 Biomedical Diagnostics
2.1.1 Biomedical Diagnostics Details
2.1.2 Biomedical Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Biomedical Diagnostics SWOT Analysis
2.1.4 Biomedical Diagnostics Product and Services
2.1.5 Biomedical Diagnostics Drug Abuse Testing Revenue, Gross Margin and Market Share (2018-2019)
2.2 Fujirebio
2.2.1 Fujirebio Details
2.2.2 Fujirebio Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Fujirebio SWOT Analysis
2.2.4 Fujirebio Product and Services
2.2.5 Fujirebio Drug Abuse Testing Revenue, Gross Margin and Market Share (2018-2019)
2.3 Bio-Rad
2.3.1 Bio-Rad Details
2.3.2 Bio-Rad Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Bio-Rad SWOT Analysis
2.3.4 Bio-Rad Product and Services
2.3.5 Bio-Rad Drug Abuse Testing Revenue, Gross Margin and Market Share (2018-2019)
2.4 BioMerieux
2.4.1 BioMerieux Details
2.4.2 BioMerieux Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 BioMerieux SWOT Analysis
2.4.4 BioMerieux Product and Services
2.4.5 BioMerieux Drug Abuse Testing Revenue, Gross Margin and Market Share (2018-2019)
2.5 Eiken
2.5.1 Eiken Details
2.5.2 Eiken Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Eiken SWOT Analysis
2.5.4 Eiken Product and Services
2.5.5 Eiken Drug Abuse Testing Revenue, Gross Margin and Market Share (2018-2019)
2.6 Abbott
2.6.1 Abbott Details
2.6.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Abbott SWOT Analysis
2.6.4 Abbott Product and Services
2.6.5 Abbott Drug Abuse Testing Revenue, Gross Margin and Market Share (2018-2019)
2.7 DiaSorin
2.7.1 DiaSorin Details
2.7.2 DiaSorin Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 DiaSorin SWOT Analysis
2.7.4 DiaSorin Product and Services
2.7.5 DiaSorin Drug Abuse Testing Revenue, Gross Margin and Market Share (2018-2019)
2.8 Dako
2.8.1 Dako Details
2.8.2 Dako Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Dako SWOT Analysis
2.8.4 Dako Product and Services
2.8.5 Dako Drug Abuse Testing Revenue, Gross Margin and Market Share (2018-2019)
2.9 Beckman Coulter
2.9.1 Beckman Coulter Details
2.9.2 Beckman Coulter Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Beckman Coulter SWOT Analysis
2.9.4 Beckman Coulter Product and Services
2.9.5 Beckman Coulter Drug Abuse Testing Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Drug Abuse Testing Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Drug Abuse Testing Players Market Share
3.2.2 Top 10 Drug Abuse Testing Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Drug Abuse Testing Revenue and Market Share by Regions
4.2 North America Drug Abuse Testing Revenue and Growth Rate (2015-2020)
4.3 Europe Drug Abuse Testing Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Drug Abuse Testing Revenue and Growth Rate (2015-2020)
4.5 South America Drug Abuse Testing Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Drug Abuse Testing Revenue and Growth Rate (2015-2020)
5 North America Drug Abuse Testing Revenue by Countries
5.1 North America Drug Abuse Testing Revenue by Countries (2015-2020)
5.2 USA Drug Abuse Testing Revenue and Growth Rate (2015-2020)
5.3 Canada Drug Abuse Testing Revenue and Growth Rate (2015-2020)
5.4 Mexico Drug Abuse Testing Revenue and Growth Rate (2015-2020)
6 Europe Drug Abuse Testing Revenue by Countries
6.1 Europe Drug Abuse Testing Revenue by Countries (2015-2020)
6.2 Germany Drug Abuse Testing Revenue and Growth Rate (2015-2020)
6.3 UK Drug Abuse Testing Revenue and Growth Rate (2015-2020)
6.4 France Drug Abuse Testing Revenue and Growth Rate (2015-2020)
6.5 Russia Drug Abuse Testing Revenue and Growth Rate (2015-2020)
6.6 Italy Drug Abuse Testing Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Drug Abuse Testing Revenue by Countries
7.1 Asia-Pacific Drug Abuse Testing Revenue by Countries (2015-2020)
7.2 China Drug Abuse Testing Revenue and Growth Rate (2015-2020)
7.3 Japan Drug Abuse Testing Revenue and Growth Rate (2015-2020)
7.4 Korea Drug Abuse Testing Revenue and Growth Rate (2015-2020)
7.5 India Drug Abuse Testing Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Drug Abuse Testing Revenue and Growth Rate (2015-2020)
8 South America Drug Abuse Testing Revenue by Countries
8.1 South America Drug Abuse Testing Revenue by Countries (2015-2020)
8.2 Brazil Drug Abuse Testing Revenue and Growth Rate (2015-2020)
8.3 Argentina Drug Abuse Testing Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Drug Abuse Testing by Countries
9.1 Middle East & Africa Drug Abuse Testing Revenue by Countries (2015-2020)
9.2 Saudi Arabia Drug Abuse Testing Revenue and Growth Rate (2015-2020)
9.3 UAE Drug Abuse Testing Revenue and Growth Rate (2015-2020)
9.4 Egypt Drug Abuse Testing Revenue and Growth Rate (2015-2020)
9.5 South Africa Drug Abuse Testing Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Drug Abuse Testing Revenue and Market Share by Type (2015-2020)
10.2 Global Drug Abuse Testing Market Forecast by Type (2019-2024)
10.3 Employment testing Revenue Growth Rate (2015-2025)
10.4 Random testing Revenue Growth Rate (2015-2025)
10.5 Reasonable testing Revenue Growth Rate (2015-2025)
10.6 Post accident testing Revenue Growth Rate (2015-2025)
10.7 Follow-up testing Revenue Growth Rate (2015-2025)
11 Global Drug Abuse Testing Market Segment by Application
11.1 Global Drug Abuse Testing Revenue Market Share by Application (2015-2020)
11.2 Drug Abuse Testing Market Forecast by Application (2019-2024)
11.3 Schools and educational institutes Revenue Growth (2015-2020)
11.4 Hospitals and healthcare units Revenue Growth (2015-2020)
11.5 Government and private departments Revenue Growth (2015-2020)
12 Global Drug Abuse Testing Market Size Forecast (2021-2025)
12.1 Global Drug Abuse Testing Market Size Forecast (2021-2025)
12.2 Global Drug Abuse Testing Market Forecast by Regions (2021-2025)
12.3 North America Drug Abuse Testing Revenue Market Forecast (2021-2025)
12.4 Europe Drug Abuse Testing Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Drug Abuse Testing Revenue Market Forecast (2021-2025)
12.6 South America Drug Abuse Testing Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Drug Abuse Testing Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Drug Abuse Testing Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Drug Abuse Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Drug Abuse Testing Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Drug Abuse Testing Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Biomedical Diagnostics Corporate Information, Location and Competitors
Table 6. Biomedical Diagnostics Drug Abuse Testing Major Business
Table 7. Biomedical Diagnostics Drug Abuse Testing Total Revenue (USD Million) (2017-2018)
Table 8. Biomedical Diagnostics SWOT Analysis
Table 9. Biomedical Diagnostics Drug Abuse Testing Product and Solutions
Table 10. Biomedical Diagnostics Drug Abuse Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Fujirebio Corporate Information, Location and Competitors
Table 12. Fujirebio Drug Abuse Testing Major Business
Table 13. Fujirebio Drug Abuse Testing Total Revenue (USD Million) (2018-2019)
Table 14. Fujirebio SWOT Analysis
Table 15. Fujirebio Drug Abuse Testing Product and Solutions
Table 16. Fujirebio Drug Abuse Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Bio-Rad Corporate Information, Location and Competitors
Table 18. Bio-Rad Drug Abuse Testing Major Business
Table 19. Bio-Rad Drug Abuse Testing Total Revenue (USD Million) (2017-2018)
Table 20. Bio-Rad SWOT Analysis
Table 21. Bio-Rad Drug Abuse Testing Product and Solutions
Table 22. Bio-Rad Drug Abuse Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. BioMerieux Corporate Information, Location and Competitors
Table 24. BioMerieux Drug Abuse Testing Major Business
Table 25. BioMerieux Drug Abuse Testing Total Revenue (USD Million) (2017-2018)
Table 26. BioMerieux SWOT Analysis
Table 27. BioMerieux Drug Abuse Testing Product and Solutions
Table 28. BioMerieux Drug Abuse Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Eiken Corporate Information, Location and Competitors
Table 30. Eiken Drug Abuse Testing Major Business
Table 31. Eiken Drug Abuse Testing Total Revenue (USD Million) (2017-2018)
Table 32. Eiken SWOT Analysis
Table 33. Eiken Drug Abuse Testing Product and Solutions
Table 34. Eiken Drug Abuse Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Abbott Corporate Information, Location and Competitors
Table 36. Abbott Drug Abuse Testing Major Business
Table 37. Abbott Drug Abuse Testing Total Revenue (USD Million) (2017-2018)
Table 38. Abbott SWOT Analysis
Table 39. Abbott Drug Abuse Testing Product and Solutions
Table 40. Abbott Drug Abuse Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. DiaSorin Corporate Information, Location and Competitors
Table 42. DiaSorin Drug Abuse Testing Major Business
Table 43. DiaSorin Drug Abuse Testing Total Revenue (USD Million) (2017-2018)
Table 44. DiaSorin SWOT Analysis
Table 45. DiaSorin Drug Abuse Testing Product and Solutions
Table 46. DiaSorin Drug Abuse Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Dako Corporate Information, Location and Competitors
Table 48. Dako Drug Abuse Testing Major Business
Table 49. Dako Drug Abuse Testing Total Revenue (USD Million) (2017-2018)
Table 50. Dako SWOT Analysis
Table 51. Dako Drug Abuse Testing Product and Solutions
Table 52. Dako Drug Abuse Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Beckman Coulter Corporate Information, Location and Competitors
Table 54. Beckman Coulter Drug Abuse Testing Major Business
Table 55. Beckman Coulter Drug Abuse Testing Total Revenue (USD Million) (2017-2018)
Table 56. Beckman Coulter SWOT Analysis
Table 57. Beckman Coulter Drug Abuse Testing Product and Solutions
Table 58. Beckman Coulter Drug Abuse Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Global Drug Abuse Testing Revenue (Million USD) by Players (2015-2020)
Table 60. Global Drug Abuse Testing Revenue Share by Players (2015-2020)
Table 61. Global Drug Abuse Testing Revenue (Million USD) by Regions (2015-2020)
Table 62. Global Drug Abuse Testing Revenue Market Share by Regions (2015-2020)
Table 63. North America Drug Abuse Testing Revenue by Countries (2015-2020)
Table 64. North America Drug Abuse Testing Revenue Market Share by Countries (2015-2020)
Table 65. Europe Drug Abuse Testing Revenue (Million USD) by Countries (2015-2020)
Table 66. Asia-Pacific Drug Abuse Testing Revenue (Million USD) by Countries (2015-2020)
Table 67. South America Drug Abuse Testing Revenue by Countries (2015-2020)
Table 68. South America Drug Abuse Testing Revenue Market Share by Countries (2015-2020)
Table 69. Middle East and Africa Drug Abuse Testing Revenue (Million USD) by Countries (2015-2020)
Table 70. Middle East and Africa Drug Abuse Testing Revenue Market Share by Countries (2015-2020)
Table 71. Global Drug Abuse Testing Revenue (Million USD) by Type (2015-2020)
Table 72. Global Drug Abuse Testing Revenue Share by Type (2015-2020)
Table 73. Global Drug Abuse Testing Revenue Forecast by Type (2021-2025)
Table 74. Global Drug Abuse Testing Revenue by Application (2015-2020)
Table 75. Global Drug Abuse Testing Revenue Share by Application (2015-2020)
Table 76. Global Drug Abuse Testing Revenue Forecast by Application (2021-2025)
Table 77. Global Drug Abuse Testing Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Drug Abuse Testing Picture
Figure 2. Global Drug Abuse Testing Revenue Market Share by Type in 2019
Figure 3. Employment testing Picture
Figure 4. Random testing Picture
Figure 5. Reasonable testing Picture
Figure 6. Post accident testing Picture
Figure 7. Follow-up testing Picture
Figure 8. Drug Abuse Testing Revenue Market Share by Application in 2019
Figure 9. Schools and educational institutes Picture
Figure 10. Hospitals and healthcare units Picture
Figure 11. Government and private departments Picture
Figure 12. Global Drug Abuse Testing Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Drug Abuse Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Drug Abuse Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Drug Abuse Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Drug Abuse Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Drug Abuse Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Drug Abuse Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Drug Abuse Testing Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Drug Abuse Testing Revenue Market Share in 2019
Figure 21. Global Top 10 Players Drug Abuse Testing Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Drug Abuse Testing Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Drug Abuse Testing Revenue Market Share by Regions (2015-2020)
Figure 25. Global Drug Abuse Testing Revenue Market Share by Regions in 2018
Figure 26. North America Drug Abuse Testing Revenue and Growth Rate (2015-2020)
Figure 27. Europe Drug Abuse Testing Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Drug Abuse Testing Revenue and Growth Rate (2015-2020)
Figure 29. South America Drug Abuse Testing Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Drug Abuse Testing Revenue and Growth Rate (2015-2020)
Figure 31. North America Drug Abuse Testing Revenue Market Share by Countries (2015-2020)
Figure 32. North America Drug Abuse Testing Revenue Market Share by Countries in 2019
Figure 33. USA Drug Abuse Testing Revenue and Growth Rate (2015-2020)
Figure 34. Canada Drug Abuse Testing Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Drug Abuse Testing Revenue and Growth Rate (2015-2020)
Figure 36. Europe Drug Abuse Testing Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Drug Abuse Testing Revenue Market Share by Countries in 2019
Figure 38. Germany Drug Abuse Testing Revenue and Growth Rate (2015-2020)
Figure 39. UK Drug Abuse Testing Revenue and Growth Rate (2015-2020)
Figure 40. France Drug Abuse Testing Revenue and Growth Rate (2015-2020)
Figure 41. Russia Drug Abuse Testing Revenue and Growth Rate (2015-2020)
Figure 42. Italy Drug Abuse Testing Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Drug Abuse Testing Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Drug Abuse Testing Revenue Market Share by Countries in 2019
Figure 45. China Drug Abuse Testing Revenue and Growth Rate (2015-2020)
Figure 46. Japan Drug Abuse Testing Revenue and Growth Rate (2015-2020)
Figure 47. Korea Drug Abuse Testing Revenue and Growth Rate (2015-2020)
Figure 48. India Drug Abuse Testing Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Drug Abuse Testing Revenue and Growth Rate (2015-2020)
Figure 50. South America Drug Abuse Testing Revenue Market Share by Countries (2015-2020)
Figure 51. South America Drug Abuse Testing Revenue Market Share by Countries in 2019
Figure 52. Brazil Drug Abuse Testing Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Drug Abuse Testing Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Drug Abuse Testing Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Drug Abuse Testing Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Drug Abuse Testing Revenue and Growth Rate (2015-2020)
Figure 57. UAE Drug Abuse Testing Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Drug Abuse Testing Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Drug Abuse Testing Revenue and Growth Rate (2015-2020)
Figure 60. Global Drug Abuse Testing Revenue Share by Type (2015-2020)
Figure 61. Global Drug Abuse Testing Revenue Share by Type in 2019
Figure 62. Global Drug Abuse Testing Market Share Forecast by Type (2021-2025)
Figure 63. Global Employment testing Revenue Growth Rate (2015-2020)
Figure 64. Global Random testing Revenue Growth Rate (2015-2020)
Figure 65. Global Reasonable testing Revenue Growth Rate (2015-2020)
Figure 66. Global Post accident testing Revenue Growth Rate (2015-2020)
Figure 67. Global Follow-up testing Revenue Growth Rate (2015-2020)
Figure 68. Global Drug Abuse Testing Revenue Share by Application (2015-2020)
Figure 69. Global Drug Abuse Testing Revenue Share by Application in 2019
Figure 70. Global Drug Abuse Testing Market Share Forecast by Application (2021-2025)
Figure 71. Global Schools and educational institutes Revenue Growth Rate (2015-2020)
Figure 72. Global Hospitals and healthcare units Revenue Growth Rate (2015-2020)
Figure 73. Global Government and private departments Revenue Growth Rate (2015-2020)
Figure 74. Global Drug Abuse Testing Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Drug Abuse Testing Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Drug Abuse Testing Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Drug Abuse Testing Revenue Market Forecast (2021-2025)
Figure 78. Europe Drug Abuse Testing Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Drug Abuse Testing Revenue Market Forecast (2021-2025)
Figure 80. South America Drug Abuse Testing Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Drug Abuse Testing Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel